Apply to trial NCT05401578

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 3Drug trial

Canakinumab for the Treatment of Postprandial Hypoglycemia

The primary objective of this randomized trial is to test whether a treatment with canakinumab is superior to placebo in patients with postprandial hypoglycemia after bariatric surgery, that is if it improves health related quality of life (mentally or physically) or reduces the risk of hypoglycemic events.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Canakinumab for the Treatment of Postprandial Hypoglycemia

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening